Product image of Lemilvo (Aripiprazole) supplied by GNH India

Lemilvo

Active Ingredient:
Aripiprazole
Origin:
EU

Lemilvo (Aripiprazole)

Aripiprazole, the active ingredient in Lemilvo, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia, bipolar I disorder (manic or mixed episodes), serves as adjunctive therapy for major depressive disorder, and reduces irritability in autistic disorder among adults and adolescents. The medication is approved in the European Union and is prescribed by qualified healthcare professionals.

GNH India supplies Lemilvo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice, ensuring product integrity throughout the supply chain.

Manufacturer / TM Owner

Accord Healthcare Polska Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Aripiprazole is employed in the management of psychiatric disorders that involve dopamine and serotonin dysregulation.

  • Schizophrenia: reduces positive and negative psychotic symptoms, improving thought organization, perception and overall functioning.
  • Bipolar I disorder (manic or mixed episodes): stabilizes mood, decreasing frequency and severity of manic episodes and preventing relapse.
  • Adjunctive treatment of major depressive disorder: enhances antidepressant efficacy when added to standard therapy, leading to greater remission rates.
  • Irritability associated with autistic disorder: lessens aggression, temper outbursts and improves emotional regulation in affected individuals.

How It Works

  • Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5‑HT1A receptors while antagonizing serotonin 5‑HT2A receptors. This mixed activity modulates dopaminergic and serotonergic neurotransmission, balancing neurotransmitter tone and thereby reducing psychotic and mood‑related symptoms without fully blocking dopamine pathways.

Side Effects

Aripiprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Akathisia: inner restlessness and urge to move.
  • Insomnia: difficulty falling or staying asleep.
  • Nausea: mild gastrointestinal upset.
  • Headache: transient cranial pain.
  • Weight gain: modest increase in body weight.

Serious or Rare Side Effects

  • Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and rigidity.
  • Tardive dyskinesia: persistent involuntary movements that may be irreversible.
  • Suicidal thoughts: emergence of suicidal ideation, especially in young adults.

Precautions & Warnings

Before initiating Lemilvo, clinicians should consider several safety measures.

  • Monitor mental status: watch for worsening depression or emergence of suicidal thoughts.
  • Assess metabolic parameters: check weight, glucose, and lipid levels periodically.
  • Evaluate cardiovascular health: be cautious in patients with history of orthostatic hypotension.
  • Use caution in hepatic impairment: dose adjustments may be required.
  • Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal symptoms.
  • Store at ambient temperature: keep tablets below 25°C in the original pack, protect from moisture.

Avoid Interactions

Aripiprazole can interact with several medicines, altering its effectiveness or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase aripiprazole plasma levels.
  • Strong CYP3A4 inducers (e.g., carbamazepine, rifampin): may reduce aripiprazole exposure.
  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis when combined.

Moderate Interactions (Monitor Closely)

  • Other antipsychotics or dopamine‑modulating agents: may increase risk of extrapyramidal symptoms.
  • CNS depressants (e.g., benzodiazepines, alcohol): may enhance sedation.
  • Antihypertensive drugs: aripiprazole may attenuate blood‑pressure‑lowering effects.

Frequently Asked Questions

Lemilvo, containing aripiprazole, is indicated for the treatment of schizophrenia, bipolar I disorder (including manic or mixed episodes), as an adjunctive therapy for major depressive disorder, and for managing irritability associated with autistic disorder in adults and adolescents.

Aripiprazole works by partially stimulating dopamine D2 and serotonin 5‑HT1A receptors while blocking serotonin 5‑HT2A receptors. This balanced activity modulates neurotransmitter pathways that are over‑active in psychosis and mood disorders, helping to stabilize mood and reduce psychotic symptoms.

The appropriate dose of Lemilvo is individualized by the prescribing clinician based on the patient’s diagnosis, severity of symptoms, prior treatment response, age, liver function and other clinical factors. No fixed regimen is provided here; the prescriber sets the exact dosage.

Safety data for aripiprazole in pregnancy and lactation are limited. The product’s pregnancy category is not established, so clinicians must weigh potential benefits against possible risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To request Lemilvo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Unlike many antipsychotics that act as pure dopamine antagonists, aripiprazole is a partial agonist at D2 receptors, which may result in a lower incidence of certain side effects such as prolactin elevation. Its mixed serotonin activity also differentiates it, offering a distinct efficacy and tolerability profile compared with older agents.

Lemilvo tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light, and store them out of reach of children.

Lemilvo is taken orally as a tablet. Patients should swallow the tablet whole with water, and it may be taken with or without food. The exact timing and any food considerations are determined by the prescribing clinician.

The most serious adverse reactions include neuroleptic malignant syndrome, a potentially fatal condition with high fever and muscle rigidity; tardive dyskinesia, which can cause persistent involuntary movements; and the emergence of suicidal thoughts, particularly in younger adults. Prompt medical attention is required if any of these occur.

Lemilvo should be avoided in individuals with known hypersensitivity to aripiprazole or any tablet excipients. It is also contraindicated in patients currently receiving monoamine oxidase inhibitors (MAOIs) or those with a history of severe neuroleptic malignant syndrome. Clinicians must assess each patient’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Aripiprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT